GEOFFREY HICKS: Open Payments
NPI 1467966671 · TWIN FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 30 payments from 10 companies in 2025. Trend: 2023 $744 · 2024 $710 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $225 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $61 |
| Xeris Pharmaceuticals, Inc. | 3 | $59 |
| Corcept Therapeutics | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
Products named: VRAYLAR, QULIPTA, CAPLYTA, RECORLEV, UBRELVY, Korlym, AUSTEDO XR, FANAPT.
Industry payments across ID — which companies pay providers there.
